Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Interventional Study on the Tolerability and Efficacy of IVIG

NCT02303093 is registered in ClinicalTrials.gov with Octapharma as lead sponsor.

NCT NCT02303093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02303093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Interventional Study on the Tolerability and Efficacy of IVIG
Lead sponsor
Octapharma
Phase
Observational
Overall status
Completed
Start date
August 1, 2011
Completion date
June 5, 2020
Enrollment
344 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

primary and secondary immunodeficiency and other conditions requiring regular administration of octagam 5% or 10% ivig